NAMALWA In Vitro High Content Screening (HCS) Assay

CAT#: ITS-0123-YF4191
Target Cell Organism: Human
Target Cell Name: NAMALWA
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide NAMALWA-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NAMALWA
Target Cell Organism
Human
Target Cell Background
NAMALWA is a B lymphocyte isolated from a three-year-old patient with Burkitt's lymphoma. This cell line was deposited by NB Finter and can be in immunology research.
Related Diseases
Burkitts Lymphoma
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry